Financial Performance - The company's revenue for Q1 2024 was ¥124,332,621.75, a decrease of 41.87% compared to ¥213,889,447.06 in the same period last year[4] - Net profit attributable to shareholders was ¥16,741,205.71, down 58.83% from ¥40,666,713.67 year-on-year[4] - Basic and diluted earnings per share decreased by 69.84% to ¥0.19 from ¥0.63 in the same period last year[4] - Total operating revenue for Q1 2024 was CNY 124,332,621.75, a decrease of 41.8% compared to CNY 213,889,447.06 in the same period last year[20] - The net profit for Q1 2024 was CNY 16,741,205.71, a decrease of 58.8% compared to CNY 40,666,713.67 in Q1 2023[21] - Total operating income for Q1 2024 was CNY 20,066,982.38, down from CNY 49,009,645.28 in the same period last year[21] - The company reported a total comprehensive income of CNY 17,005,810.60 for Q1 2024, down from CNY 38,703,148.36 in Q1 2023[21] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly to ¥74,538,568.94, compared to a negative cash flow of ¥24,462,228.52 in the previous year, representing a 404.71% improvement[4] - Cash flow from operating activities generated a net amount of CNY 74,538,568.94, a significant improvement from a net outflow of CNY 24,462,228.52 in Q1 2023[23] - Cash and cash equivalents increased to CNY 536,014,618.49 from CNY 486,901,359.23, reflecting a growth of 10.4%[18] - Cash and cash equivalents at the end of Q1 2024 totaled CNY 536,014,618.49, compared to CNY 223,449,259.92 at the end of Q1 2023[24] - Operating cash inflows totaled CNY 181,469,978.88, an increase from CNY 141,122,526.44 in the previous year[23] - The company incurred total operating cash outflows of CNY 106,931,409.94, down from CNY 165,584,754.96 in Q1 2023[23] - The net cash flow from investing activities was negative CNY 21,447,108.10, compared to a positive CNY 38,011,094.89 in Q1 2023[23] - The company experienced a foreign exchange impact of CNY 1,074,957.31 on cash and cash equivalents during the quarter[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,295,075,903.84, a slight decrease of 0.67% from ¥2,310,635,609.21 at the end of the previous year[4] - Total assets decreased to CNY 2,295,075,903.84 from CNY 2,310,635,609.21, a decline of 0.7%[19] - Total liabilities decreased to CNY 105,693,583.02 from CNY 139,630,803.20, a reduction of 24.3%[19] - The company's total equity increased to CNY 2,189,382,320.82 from CNY 2,171,004,806.01, reflecting a growth of 0.8%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 12,569, with the largest shareholder holding 48.66% of the shares[10] - The company reported a total of 65,634,680 shares with 1,109,680 shares released from restrictions during the period, leaving 64,525,000 shares under restriction[13] - Kingchem (China) Holding LLC holds 41,863,773 shares, which are subject to a lock-up until February 3, 2027[13] - The top ten unrestricted shareholders include Bai Qingliang with 341,400 shares and Xingye Bank with 215,000 shares[11] - The company has a total of 7,500,000 shares held by Qilu (Xiamen) Equity Investment Partnership, which are also subject to a lock-up until August 3, 2024[13] - The company has no changes in the top ten shareholders due to securities lending or borrowing activities[11] - The total number of shares held by the top ten unrestricted shareholders is 1,109,680 shares, which were released from restrictions on February 5, 2024[13] - The company has a total of 3,933,911 shares held by Blue Economy Zone Industrial Investment Fund, which are subject to a lock-up until August 3, 2024[13] Operational Efficiency - The company experienced a 39.37% reduction in operating costs, which amounted to ¥75,352,404.76 compared to ¥124,289,242.50 in the previous year[8] - Total operating costs for Q1 2024 were CNY 110,839,890.09, down 32.3% from CNY 164,128,214.79 in the previous year[20] - Research and development expenses for Q1 2024 were CNY 6,964,404.48, down from CNY 8,197,380.38 in the previous year, indicating a decrease of 15.0%[20] - Accounts receivable decreased by 46.04% to ¥55,911,064.26, primarily due to the collection of large receivables from the beginning of the year[7] - Accounts receivable decreased significantly to CNY 55,911,064.26 from CNY 103,618,656.11, a reduction of 46.0%[18] Governance - The company held its first temporary shareholders' meeting on January 9, 2024, to elect the second board of directors and supervisory board[15] - The company has completed the election of its second board of directors and supervisory board, ensuring continuity in governance[15] - The company has no preferred shareholders or changes in restricted shares during the reporting period[12] Government Support and Investment - The company reported a significant increase in government subsidies, totaling ¥1,236,991.05, which is a 165.28% increase compared to ¥466,304.69 in the previous year[8] - Investment income rose to ¥1,596,683.03, marking an increase of 185.93% from ¥558,421.85 year-on-year[8] - The company reported a net profit of CNY 1,596,683.03 from investments, an increase compared to CNY 558,421.85 in the previous year[20]
金凯生科(301509) - 2024 Q1 - 季度财报